文献速递生殖医学

反复种植失败患者差异表达microRNA发现新平台

A novel platform for discovery of differentially expressed microRNAs in patients with repeated implantation failure.
PubMed 文献 · Fertil Steril · 2021-04-03

本研究通过系统分析IVF患者子宫内膜microRNA谱,在25例发现队列中鉴定出hsa-miR-20b-5p、hsa-miR-155-5p和hsa-miR-718三个miRNA特征,并在11例验证队列中验证,该三miRNA特征预测反复种植失败的准确率超过90%。

要点

  • 子宫内膜miRNA谱可用于预测反复种植失败风险
  • 三miRNA特征(hsa-miR-20b-5p、hsa-miR-155-5p、hsa-miR-718)预测RIF准确率>90%
  • PanelChip平台可系统分析IVF患者子宫内膜miRNA

核心结论

  • 特定子宫内膜miRNA可作为诊断生物标志物预测反复种植失败,有望提高种植成功率。

研究设计与样本

  • 系统分析接受IVF患者子宫内膜miRNA谱的研究,发现队列25例不孕患者,验证队列11例患者。

主要发现

  • 通过无限组合特征搜索算法从25例发现队列中鉴定出hsa-miR-20b-5p、hsa-miR-155-5p和hsa-miR-718三个主要miRNA特征。
  • 在11例验证队列中以这三个miRNA作为生物标志物,三miRNA特征预测反复种植失败的准确率>90%。

关键数值与推荐

  • 三miRNA特征(hsa-miR-20b-5p、hsa-miR-155-5p、hsa-miR-718)预测RIF准确率>90%。

临床怎么用

  • 可考虑检测子宫内膜hsa-miR-20b-5p、hsa-miR-155-5p和hsa-miR-718表达水平以评估反复种植失败风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify predictor microRNAs (miRNAs) from patients with repeated implantation failure (RIF). DESIGN: Systemic analysis of miRNA profiles from the endometrium of patients undergoing in vitro fertilization (IVF). SETTING: University research institute, private IVF center, and molecular testing laboratory. PATIENT(S): Twenty five infertile patients in the discovery cohort and 11 patients in the validation cohort. INTERVENTIONS(S): None. MAIN OUTCOME MEASURE(S): A signature set of miRNA associated with the risk of RIF. RESULT(S): We designed a reproductive disease-related PanelChip to access endometrium miRNA profiles in patients undergoing IVF. Three major miRNA signatures, including hsa-miR-20b-5p, hsa-miR-155-5p, and hsa-miR-718, were identified using infinite combination signature search algorithm analysis from 25 patients in the discovery cohort undergoing IVF. These miRNAs were used as biomarkers in the validation cohort of 11 patients. Finally, the 3-miRNA signature was capable of predicting patients with RIF with an accuracy >90%. CONCLUSION(S): Our findings indicated that specific endometrial miRNAs can be applied as diagnostic biomarkers to predict RIF. Such information will definitely help to increase the success rate of implantation practice.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Chen CH, Lu F, Yang WJ, et al. A novel platform for discovery of differentially expressed microRNAs in patients with repeated implantation failure. Fertil Steril. 2021. PMID: 33823989. doi:10.1016/j.fertnstert.2021.01.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。